● Recruiting

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Condition: Lupus Nephritis · Sponsor: Novartis Pharmaceuticals

PhasePhase 2

Planned participants240

Who can joinAll sexes, 18 Years to 100 Years

Healthy volunteersNo

About this study

The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (103)

AKDHC Medical Research ServicesLLC	Phoenix, Arizona, United States	Withdrawn
Kaiser Permanente Fontana	Fontana, California, United States	Withdrawn
Univ Calif Irvine	Irvine, California, United States	Withdrawn
Ronald Reagan UCLA Medical Center	Los Angeles, California, United States	Recruiting
Loma Linda University	San Bernardino, California, United States	Active Not Recruiting
Olive View UCLA Medical Center	Sylmar, California, United States	Active Not Recruiting
University of Colorado Denver	Aurora, Colorado, United States	Recruiting
Royal Research Corp	Hollywood, Florida, United States	Recruiting
Mayo Clinic Jacksonville	Jacksonville, Florida, United States	Recruiting
Nephrology Associates Of Central FL	Orlando, Florida, United States	Active Not Recruiting
Florida Kidney Physicians	Riverview, Florida, United States	Recruiting
Florida Kidney Physicians	Riverview, Florida, United States	Recruiting

+ 91 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05268289